124 related articles for article (PubMed ID: 18514188)
1. Genistein induces apoptosis in ovarian cancer cells via different molecular pathways depending on Breast Cancer Susceptibility gene-1 (BRCA1) status.
Thasni KA; Rojini G; Rakesh SN; Ratheeshkumar T; Babu MS; Srinivas G; Banerji A; Srinivas P
Eur J Pharmacol; 2008 Jul; 588(2-3):158-64. PubMed ID: 18514188
[TBL] [Abstract][Full Text] [Related]
2. AKT and p21 WAF1/CIP1 as potential genistein targets in BRCA1-mutant human breast cancer cell lines.
Privat M; Aubel C; Arnould S; Communal Y; Ferrara M; Bignon YJ
Anticancer Res; 2010 Jun; 30(6):2049-54. PubMed ID: 20651350
[TBL] [Abstract][Full Text] [Related]
3. Anticancer effect of genistein on BG-1 ovarian cancer growth induced by 17 β-estradiol or bisphenol A via the suppression of the crosstalk between estrogen receptor α and insulin-like growth factor-1 receptor signaling pathways.
Hwang KA; Park MA; Kang NH; Yi BR; Hyun SH; Jeung EB; Choi KC
Toxicol Appl Pharmacol; 2013 Nov; 272(3):637-46. PubMed ID: 23933164
[TBL] [Abstract][Full Text] [Related]
4. Estrogen-dependent cell signaling and apoptosis in BRCA1-blocked BG1 ovarian cancer cells in response to plumbagin and other chemotherapeutic agents.
Thasni KA; Rakesh S; Rojini G; Ratheeshkumar T; Srinivas G; Priya S
Ann Oncol; 2008 Apr; 19(4):696-705. PubMed ID: 18187487
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer cell response to genistein is conditioned by BRCA1 mutations.
Privat M; Aubel C; Arnould S; Communal Y; Ferrara M; Bignon YJ
Biochem Biophys Res Commun; 2009 Feb; 379(3):785-9. PubMed ID: 19126406
[TBL] [Abstract][Full Text] [Related]
6. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
7. Genistein inhibits NF-kappa B activation in prostate cancer cells.
Davis JN; Kucuk O; Sarkar FH
Nutr Cancer; 1999; 35(2):167-74. PubMed ID: 10693171
[TBL] [Abstract][Full Text] [Related]
8. Genistein's "ER-dependent and independent" actions are mediated through ER pathways in ER-positive breast carcinoma cell lines.
Shao ZM; Shen ZZ; Fontana JA; Barsky SH
Anticancer Res; 2000; 20(4):2409-16. PubMed ID: 10953303
[TBL] [Abstract][Full Text] [Related]
9. Genistein-induced upregulation of p21WAF1, downregulation of cyclin B, and induction of apoptosis in prostate cancer cells.
Davis JN; Singh B; Bhuiyan M; Sarkar FH
Nutr Cancer; 1998; 32(3):123-31. PubMed ID: 10050261
[TBL] [Abstract][Full Text] [Related]
10. Genistein-induced apoptosis and autophagocytosis in ovarian cancer cells.
Gossner G; Choi M; Tan L; Fogoros S; Griffith KA; Kuenker M; Liu JR
Gynecol Oncol; 2007 Apr; 105(1):23-30. PubMed ID: 17234261
[TBL] [Abstract][Full Text] [Related]
11. [Proliferation inhibition and apoptosis onset in human ovarian carcinoma cell line SKOV3 induced by Genistein].
Li Y; Mi C
Ai Zheng; 2003 Jun; 22(6):586-91. PubMed ID: 12948406
[TBL] [Abstract][Full Text] [Related]
12. The topoisomerase II inhibitor, genistein, induces G2/M arrest and apoptosis in human malignant glioma cell lines.
Schmidt F; Knobbe CB; Frank B; Wolburg H; Weller M
Oncol Rep; 2008 Apr; 19(4):1061-6. PubMed ID: 18357397
[TBL] [Abstract][Full Text] [Related]
13. Structure activity relationship of plumbagin in BRCA1 related cancer cells.
K A T; T R; G R; K C S; Nair RS; G S; Banerji A; Somasundaram V; Srinivas P
Mol Carcinog; 2013 May; 52(5):392-403. PubMed ID: 22290577
[TBL] [Abstract][Full Text] [Related]
14. Antisense blocking of BRCA1 enhances sensitivity to plumbagin but not tamoxifen in BG-1 ovarian cancer cells.
Srinivas G; Annab LA; Gopinath G; Banerji A; Srinivas P
Mol Carcinog; 2004 Jan; 39(1):15-25. PubMed ID: 14694444
[TBL] [Abstract][Full Text] [Related]
15. p53-independent apoptosis induced by genistein in lung cancer cells.
Lian F; Li Y; Bhuiyan M; Sarkar FH
Nutr Cancer; 1999; 33(2):125-31. PubMed ID: 10368806
[TBL] [Abstract][Full Text] [Related]
16. Genistein exerts multiple suppressive effects on human breast carcinoma cells.
Shao ZM; Wu J; Shen ZZ; Barsky SH
Cancer Res; 1998 Nov; 58(21):4851-7. PubMed ID: 9809990
[TBL] [Abstract][Full Text] [Related]
17. The soy isoflavone genistein promotes apoptosis in mammary epithelial cells by inducing the tumor suppressor PTEN.
Dave B; Eason RR; Till SR; Geng Y; Velarde MC; Badger TM; Simmen RC
Carcinogenesis; 2005 Oct; 26(10):1793-803. PubMed ID: 15905199
[TBL] [Abstract][Full Text] [Related]
18. [Mechanism of growth inhibition by genistein of human breast carcinoma].
Shao Z; Shen Z
Zhonghua Zhong Liu Za Zhi; 1999 Sep; 21(5):325-8. PubMed ID: 11776565
[TBL] [Abstract][Full Text] [Related]
19. Genistein-induced G2-M arrest, p21WAF1 upregulation, and apoptosis in a non-small-cell lung cancer cell line.
Lian F; Bhuiyan M; Li YW; Wall N; Kraut M; Sarkar FH
Nutr Cancer; 1998; 31(3):184-91. PubMed ID: 9795970
[TBL] [Abstract][Full Text] [Related]
20. Effects of diverse dietary phytoestrogens on cell growth, cell cycle and apoptosis in estrogen-receptor-positive breast cancer cells.
Sakamoto T; Horiguchi H; Oguma E; Kayama F
J Nutr Biochem; 2010 Sep; 21(9):856-64. PubMed ID: 19800779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
